Medicare

Medicare Group QSC

MCGSStocksQatar Stock ExchangeHealthcare

Financials

1-5

	CurrentMar 10, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Market & Price
Market Capitalization	1.47B	1.87B	1.98B	1.46B	1.27B
Market Cap Growth	+21.8%	+45.7%	+50.8%	+21.2%	+7.6%
Enterprise Value	1.56B	1.96B	2.08B	1.52B	1.35B
Last Close Price	5.22	6.63	7.04	5.19	4.33
Valuation Multiples
PE Ratio	19.34	24.55	23.01	16.23	18.08
PS Ratio	2.93	3.71	3.83	2.79	3.24
PB Ratio	1.43	1.81	1.95	1.47	1.24
P/TBV Ratio	1.43	1.81	1.95	1.47	1.24
P/FCF Ratio	41.83	53.10	43.34	26.66	30.04
P/OCF Ratio	15.45	19.61	21.29	13.45	15.24
EV/Sales Ratio	3.10	3.90	4.03	2.91	3.44
EV/EBITDA Ratio	17.45	21.99	21.29	14.97	17.36
EV/EBIT Ratio	24.80	31.25	28.36	19.65	22.51
EV/FCF Ratio	44.26	55.77	45.57	27.75	31.85
Leverage & Capital
Debt / Equity Ratio	0.15	0.15	0.16	0.17	0.17
Debt / EBITDA Ratio	1.68	2.02	1.67	1.76	1.93
Debt / FCF Ratio	4.27	4.27	3.50	3.07	4.17
Net Debt / Equity Ratio	0.08	0.08	0.09	0.10	0.06
Net Debt / EBITDA Ratio	0.96	0.96	0.96	1.00	0.77
Net Debt / FCF Ratio	2.43	2.43	2.06	1.86	1.41
Efficiency & Liquidity
Asset Turnover	0.37	0.34	0.37	0.36	0.40
Inventory Turnover	11.48	12.55	10.26	11.28	10.71
Quick Ratio	1.02	1.02	1.15	1.06	1.33
Current Ratio	1.34	1.34	1.57	1.45	1.75
Returns & Yields
Return on Equity (ROE)	+5.4%	+8.3%	+7.8%	+8.5%	+9.6%
Return on Assets (ROA)	+2.1%	+3.1%	+3.1%	+2.9%	+4.0%
Return on Capital Employed (ROCE)	+5.1%	+5.1%	+5.9%	+6.3%	+4.8%
Earnings Yield	+5.2%	+4.1%	+4.3%	+6.2%	+5.5%
FCF Yield	+2.4%	+1.9%	+2.3%	+3.8%	+3.3%
Dividend Yield	+4.2%	+3.3%	—	—	—
Payout Ratio	+73.4%	0.0%	+0.3%	+284.2%	0.0%
Buyback Yield / Dilution	—	-0.7%	+0.7%	—	+0.6%
Total Shareholder Return	+4.2%	+2.7%	+0.7%	—	+0.6%

1-5

	CurrentMar 10, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Market & Price
Market Capitalization	1.47B	1.87B	1.98B	1.46B	1.27B
Market Cap Growth	+21.8%	+45.7%	+50.8%	+21.2%	+7.6%
Enterprise Value	1.56B	1.96B	2.08B	1.52B	1.35B
Last Close Price	5.22	6.63	7.04	5.19	4.33
Valuation Multiples
PE Ratio	19.34	24.55	23.01	16.23	18.08
PS Ratio	2.93	3.71	3.83	2.79	3.24
PB Ratio	1.43	1.81	1.95	1.47	1.24
P/TBV Ratio	1.43	1.81	1.95	1.47	1.24
P/FCF Ratio	41.83	53.10	43.34	26.66	30.04
P/OCF Ratio	15.45	19.61	21.29	13.45	15.24
EV/Sales Ratio	3.10	3.90	4.03	2.91	3.44
EV/EBITDA Ratio	17.45	21.99	21.29	14.97	17.36
EV/EBIT Ratio	24.80	31.25	28.36	19.65	22.51
EV/FCF Ratio	44.26	55.77	45.57	27.75	31.85
Leverage & Capital
Debt / Equity Ratio	0.15	0.15	0.16	0.17	0.17
Debt / EBITDA Ratio	1.68	2.02	1.67	1.76	1.93
Debt / FCF Ratio	4.27	4.27	3.50	3.07	4.17
Net Debt / Equity Ratio	0.08	0.08	0.09	0.10	0.06
Net Debt / EBITDA Ratio	0.96	0.96	0.96	1.00	0.77
Net Debt / FCF Ratio	2.43	2.43	2.06	1.86	1.41
Efficiency & Liquidity
Asset Turnover	0.37	0.34	0.37	0.36	0.40
Inventory Turnover	11.48	12.55	10.26	11.28	10.71
Quick Ratio	1.02	1.02	1.15	1.06	1.33
Current Ratio	1.34	1.34	1.57	1.45	1.75
Returns & Yields
Return on Equity (ROE)	+5.4%	+8.3%	+7.8%	+8.5%	+9.6%
Return on Assets (ROA)	+2.1%	+3.1%	+3.1%	+2.9%	+4.0%
Return on Capital Employed (ROCE)	+5.1%	+5.1%	+5.9%	+6.3%	+4.8%
Earnings Yield	+5.2%	+4.1%	+4.3%	+6.2%	+5.5%
FCF Yield	+2.4%	+1.9%	+2.3%	+3.8%	+3.3%
Dividend Yield	+4.2%	+3.3%	—	—	—
Payout Ratio	+73.4%	0.0%	+0.3%	+284.2%	0.0%
Buyback Yield / Dilution	—	-0.7%	+0.7%	—	+0.6%
Total Shareholder Return	+4.2%	+2.7%	+0.7%	—	+0.6%